Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-20-010245
Filing Date
2020-10-29
Accepted
2020-10-29 13:44:10
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 37757
2 filename2.txt TEXT-EXTRACT 16652
  Complete submission text file 0000000000-20-010245.txt   69254
Mailing Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109
Business Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109 206-456-2900
Silverback Therapeutics, Inc. (Filed for) CIK: 0001671858 (see all company filings)

EIN.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations